Abdul Raoof Lamoshi

4 statements · 1 topic · summaries given as host listed separately

Nothing matches these filters — clear the search or widen the filters.

Abdul's statements about Esophageal Atresia 4 statements

Open the Esophageal Atresia collection →

Glycopyrrolate for Anastomtic Dehiscence in Esophageal Atresia

Statement The results were both statistically and clinically significant Open
Statement The study was a very well done randomized controlled trial with a very good sample size Open

Glycopyrrolate for Anastomtic Dehiscence in Esophageal Atresia

Statement The results were both statistically and clinically significant Open
Statement The study was a randomized controlled trial with a very good sample size Open

Summaries Abdul gave as host · 6 summaries

Recaps of other experts' statements, not Abdul's own clinical position.

Summaries Abdul gave as host · Esophageal Atresia 6 summaries

Open the Esophageal Atresia collection →

Glycopyrrolate for Anastomtic Dehiscence in Esophageal Atresia

Host summary Abdul Raoof Lamoshi summarizing a resource: Oral feeding was achieved in 71% of the glycopyrrolate treatment group compared to only 14% of the placebo group Open
Host summary Abdul Raoof Lamoshi summarizing a resource: Chest tube output was 124 mL in the glycopyrrolate treatment group compared to 370 mL in the placebo group Open
Host summary Abdul Raoof Lamoshi summarizing a resource: Leak resolution was accomplished in 76% of the glycopyrrolate treatment group compared to 29% of the placebo group Open

Glycopyrrolate for Anastomtic Dehiscence in Esophageal Atresia

Host summary Abdul Raoof Lamoshi summarizing a resource: Leak resolution was accomplished in 76% of the glycopyrrolate treatment group compared to 29% of the placebo group Open
Host summary Abdul Raoof Lamoshi summarizing a resource: Chest tube output was 124 mL in the glycopyrrolate treatment group compared to 370 mL in the placebo group Open
Host summary Abdul Raoof Lamoshi summarizing a resource: Oral feeding was achieved in 71% of the glycopyrrolate treatment group compared to only 14% of the placebo group Open